Intraductal papillary mucinous neoplasms and other pancreatic cystic lesions.
Pancreatic cystic neoplasms are being increasingly recognized, even in the absence of symptoms, in large part, due to markedly improved imaging modalities such as magnetic resonance imaging (MRI)/magnetic resonance cholangio pancreatography (MRCP) and computer tomography (CT) scanning. During the past 2 decades, better imaging of these cystic lesions has resulted in definition of different types, including pancreatic intraductal papillary mucinous neoplasms (IPMN). While IPMN represent only a distinct minority of all pancreatic cancers, they appear to be a relatively frequent neoplastic form of pancreatic cystic neoplasm. Moreover, IPMN have a much better outcome and prognosis compared to pancreatic ductal adenocarcinomas. Therefore, recognition of this entity is exceedingly important for the clinician involved in diagnosis and further evaluation of a potentially curable form of pancreatic cancer.
Freeman
Hugh-James
HJ
Department of Medicine, University of British Columbia Hospital, Vancouver V6T 1W5, Canada. hugfree@shaw.ca
D000230:Adenocarcinoma / Q000473:pathology; D021441:Carcinoma, Pancreatic Ductal / Q000145:classification / Q000473:pathology*; D018293:Cystadenoma, Serous / Q000473:pathology; D005260:Female; D006801:Humans; D008297:Male; D018297:Neoplasms, Cystic, Mucinous, and Serous / Q000145:classification / Q000473:pathology*; D009375:Neoplasms, Glandular and Epithelial / Q000145:classification / Q000473:pathology*; D010181:Pancreatic Cyst / Q000145:classification / Q000473:pathology*; D010190:Pancreatic Neoplasms / Q000145:classification / Q000473:pathology*; D009626:Terminology as Topic